Abstract
Study Objective To assess the prevalence of several impairing behavioral health domains in stable patients presenting to the emergency department (ED) through the use of computer adaptive testing and the association among the domains, standard assessments, and ED utilization.
Methods This was a single-center observational study of 828 randomly selected adult patients presenting to the ED from May 2019 to March 2020. The main outcomes of interest were the self-administered, validated computer adaptive assessments of suicidality, depression, anxiety, PTSD, and substance abuse using computer adaptive testing, the CAT-MH™. We estimated the association among the CAT-MH™ subscales, standard assessments, and the number of ED visits in the year prior and 30 days after enrollment.
Results The proportion of those who scored above the threshold of low/mild risk were: 24.1% (suicidality), 8.3% (depression), 16.5% (anxiety), 12.3% (PTSD), and 20.4% (substance use). While the CAT-MH™ subscales were highly correlated with other self-report assessments, they were not highly associated with standard ED assessments of suicidality. When examining associations with ED use, for example, individuals who had two or more ED visits in the prior year had 51% increased odds of being in the intermediate-high suicide risk category (95% Confidence Interval [CI], 1.03-2.23) compared to those with zero prior ED visits.
Conclusion The CAT-MH™ can document the high prevalence of mental health conditions in the ED, which were missed by standard ED practices. Mental health problems are associated with ED utilization in a population of patients presenting largely for somatic complaints.
Competing Interest Statement
R. D. Gibbons is a founder of Adaptive Testing Technologies, which distributes the Computerized Adaptive Test-Mental Health suite of computerized adaptive tests (CAT-MH is a trademark of Adaptive Testing Technologies); the terms of this arrangement have been reviewed and approved by the University of Chicago in accordance with its conflicts of interest policies.
Funding Statement
The study was supported by the Responding to the Additions Crisis Grand Challenge from Indiana University. Lauren OReilly was supported by the National Institute of Mental Health of the National Institutes of Health (1F31MH121039-01). Paul Musey was supported by the National Heart, Lung, and Blood Institute as a Trans NIH K12 (K12HL133310) Scholar. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The supporters had no role in the design, analysis, interpretation, or publication of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Indiana University School of Medicine Institutional Review Board (protocol no.1904527368) and all participants gave their informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Previous Presentation: Lauren O’Reilly presented a selection of the current analyses as a poster at the IASR/AFSP International Summit on Suicide Research from October 24-27, 2021 (virtual conference). Alex Card presented a selection of the current analyses as a poster at the Society for Academic Emergency Medicine National Meeting from May 12-15, 2020 (virtual conference).
Funding: The study was supported by the Responding to the Additions Crisis Grand Challenge from Indiana University. Lauren O’Reilly was supported by the National Institute of Mental Health of the National Institutes of Health (1F31MH121039-01). Paul Musey was supported by the National Heart, Lung, and Blood Institute as a Trans NIH K12 (K12HL133310) Scholar. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The supporters had no role in the design, analysis, interpretation, or publication of this study.
Conflicts of Interest: R. D. Gibbons is a founder of Adaptive Testing Technologies, which distributes the Computerized Adaptive Test—Mental Health suite of computerized adaptive tests (CAT-MH is a trademark of Adaptive Testing Technologies); the terms of this arrangement have been reviewed and approved by the University of Chicago in accordance with its conflicts of interest policies. The authors report no additional financial or other relationship relevant to the subject of this article.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
